血压(BP)是一个重要的体征,它的测量对于诊断和治疗高血压至关重要。因此,BP监测仪的准确性至关重要,但不幸的是,市场上很少有设备使用已建立的协议进行了验证。STRIDEBP(www.stridebp.org)是一个国际非营利组织,其使命是提高BP测量的准确性和高血压的诊断。它拥有着名的科学顾问委员会,并与欧洲高血压学会有隶属关系,国际高血压学会,和世界高血压联盟.STRIDEBP提供准确的办公室清单,走动,和家用BP监测仪。STRIDEBP对419份已发布的验证(270篇文章和260台设备)进行了系统评价。在这些出版物中,50(12%)的验证被拒绝,而STRIDEBP拒绝129(31%)(P<.001)。在出版物中批准但被STRIDEBP拒绝的79项验证中,7名(9%)因设备不准确而被拒绝,72名(91%)因研究质量不足(执行,分析,和报告)。必须避免进行和报告已发布验证时的错误。同行评审必须确定已遵守验证研究所有方面的综合清单。通过实施器械验证通用标准和STRIDEBP全球传播准确器械信息,有望提高BP测量的质量和准确性。这应该对全球高血压的诊断和管理产生积极影响。
Blood pressure (BP) is a vital sign, and its measurement is essential for diagnosing and treating hypertension. The accuracy of BP monitors is therefore essential, but unfortunately very few devices available on the market have been validated using an established protocol. STRIDE BP (www.stridebp.org) is an international nonprofit organization with the mission to improve the accuracy of BP measurement and the diagnosis of hypertension. It has a prestigious Scientific Advisory Board and operates in affiliation with the European Society of Hypertension, the International Society of Hypertension, and the World Hypertension League. STRIDE BP provides lists of accurate office, ambulatory, and home BP monitors. STRIDE BP performed a systematic
review of 419 published validations (270 articles and 260 devices). In these publications, 50 (12%) of the validations were rejected compared with 129 (31%) rejected by STRIDE BP (P < .001). Of 79 validations approved in publications but rejected by STRIDE BP, 7 (9%) were rejected due to device inaccuracy and 72 (91%) due to inadequate study quality (execution, analysis, and reporting). Errors in conducting and reporting published validations must be avoided. Peer
review must ascertain that a comprehensive checklist of all aspects of a validation study have been adhered to. The implementation of a Universal Standard for device validation and the global dissemination of information on accurate devices by STRIDE BP are expected to improve the quality and accuracy of BP measurement, which should have a positive impact on the diagnosis and management of hypertension globally.